UK Renal Registry 10th Annual Report 2007 Fig 9.1 Annual change in percentage of dialysis patients with serum phosphate < 1.8mmol/L and ≥1.1 -≤1.8mmol/L.

Slides:



Advertisements
Similar presentations
UK Renal Registry 13th Annual Report Figure 12.1: Median height z-scores for transplant patients in 2009.
Advertisements

UK Renal Registry 16th Annual Report Figure Data completeness for key variables, stratified by first modality HD = haemodialysis; PD = peritoneal.
UK Renal Registry 17th Annual Report Figure Data completeness for key variables, stratified by first modality DOB = date of birth; PRD = primary.
UK Renal Registry 15th Annual Report Figure One year death rate per 1,000 patient years by UK country and age group for prevalent dialysis.
UK Renal Registry 16th Annual Report Figure 8.1. Trend in 1 year after 90 day incident patient survival by first modality, 2005–2011 cohort (adjusted to.
UK Renal Registry 17th Annual Report Figure 9.1. Median height z-scores for transplant patients
UK Renal Registry 16th Annual Report Figure Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2012.
UK Renal Registry 14th Annual Report Figure 8.1. Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2010.
UK Renal Registry 17th Annual Report Figure 8.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit.
UK Renal Registry 17th Annual Report Figure 3.1. Transplant prevalence rate per million population by age and gender on 31/12/2013.
UK Renal Registry 14th Annual Report Figure 3.1. Transplant prevalence rate per million population by age and gender on 31/12/2010.
UK Renal Registry 9 th Annual Report 2006 Fig 9.1 Percentage of patients with serum phosphate
UK Renal Registry 17th Annual Report Figure Percentage of patients waitlisted for a kidney transplant by renal centre, prior to or within two years.
UK Renal Registry 17th Annual Report Figure 2.1. Prevalence rates per million population by age group and UK country on 31/12/2013.
UK Renal Registry 10th Annual Report 2007 Fig 3.1 Incident rates in the countries of the UK:
UK Renal Registry 10th Annual Report 2007 Fig 10.1 Summary of BP achievements.
UK Renal Registry 9 th Annual Report 2006 Fig 10.1 Systolic BP mm Hg (pre-HD)
UK Renal Registry 16th Annual Report Figure Summary of BP achievements.
UK Renal Registry 14th Annual Report Figure Summary of BP achievements.
UK Renal Registry 9 th Annual Report 2006 Fig 11.1 UK transplantation prevalence rate per million population by age and gender on 31/12/2005.
UK Renal Registry 17th Annual Report Figure 1.1. RRT incidence rates in the countries of the UK 1990–2013.
UK Renal Registry 10th Annual Report 2007 Fig 8.1 Median haemoglobin for incident dialysis patients at start of dialysis treatment.
Highlights from the Annual Report UK Renal Registry 2013 Annual Audit Meeting Dr Catriona Shaw Registrar, UK Renal Registry.
UK Renal Registry 15th Annual Report Figure 6.1. Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2011.
UK Renal Registry 16th Annual Report Figure Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit.
CHAPTER 9: Chronic Kidney Disease – Mineral and Bone DisorderKok Lai Sun Ching Chen Hua Fan Kin Sing Rozina Ghazalli Liew Yew Fong Source: 21 st MDTR Report.
UK Renal Registry 17th Annual Report Figure Box and whisker plot of renal centres’ MRSA rates per 100 dialysis patient years by reporting year.
UK Renal Registry 16th Annual Report Figure Median height z-scores for transplant patients
UK Renal Registry 16th Annual Report Figure Box and whisker plot of MRSA rates by renal centre per 100 prevalent dialysis patients per year by reporting.
Chapter 3 Death and Survival on Dialysis Wong Hin Seng Ong Loke Meng Source: 20 th MDTR Report 2012, NRR.
UK Renal Registry 15th Annual Report Figure 7.1. Median height z-scores for transplant patients
UK Renal Registry 9 th Annual Report 2006 Fig 14.1 Height Z scores for ERF patients aged 2 to 16 years in 2005.
UK Renal Registry 18th Annual Report
UK Renal Registry 10th Annual Report 2007
UK Renal Registry 15th Annual Report
Fig 7.1 Median URR achieved in each renal unit
UK Renal Registry 16th Annual Report
UK Renal Registry 18th Annual Report
UK Renal Registry 9th Annual Report 2006
UK Renal Registry 10th Annual Report 2007
UK Renal Registry 19th Annual Report
Peer Review Oct 2017 Haemodialysis Graphs.
CHAPTER 3 Death and Survival on Dialysis
UK Renal Registry 13th Annual Report
UK Renal Registry 11th Annual Report
UK Renal Registry 11th Annual Report 2008
UK Renal Registry 13th Annual Report
Fig 6.1 Frequency of ischaemic heart disease in incident patients
CHAPTER 9 Chronic Kidney Disease – Mineral and Bone Disorder
UK Renal Registry 13th Annual Report
UK Renal Registry 11th Annual Report
Renal Association UK Renal Registry.
UK Renal Registry 14th Annual Report
UK Renal Registry 16th Annual Report
Renal Association UK Renal Registry.
UK Renal Registry 12th Annual Report
UK Renal Registry 14th Annual Report
UK Renal Registry 16th Annual Report
UK Renal Registry 14th Annual Report
Fig 7.1 Median URR achieved in each centre, 2006
UK Renal Registry 10th Annual Report 2007
UK Renal Registry 12th Annual Report
UK Renal Registry 13th Annual Report
UK Renal Registry 16th Annual Report
Renal Association UK Renal Registry.
UK Renal Registry 11th Annual Report
UK Renal Registry 9th Annual Report 2006
Stock and Flow of Peritoneal Dialysis Patients Australia
Stock and Flow of Haemodialysis Patients Australia
Renal Association UK Renal Registry.
Presentation transcript:

UK Renal Registry 10th Annual Report 2007 Fig 9.1 Annual change in percentage of dialysis patients with serum phosphate < 1.8mmol/L and ≥1.1 -≤1.8mmol/L E,W and NI

UK Renal Registry 10th Annual Report 2007 Fig 9.2 Annual change in percentage with serum phosphate between mmol/L, >1.8mmol/L and <1.1mmol/L UK

UK Renal Registry 10th Annual Report 2007 Fig 9.3 Median serum phosphate mmol/L: dialysis

UK Renal Registry 10th Annual Report 2007 Fig 9.4 Percentage of patients with serum phosphate <1.8mmol/L : HD

UK Renal Registry 10th Annual Report 2007 Fig 9.5 Confidence in centre ranking for percentage of HD patients with phosphate<1.8mmol/L

UK Renal Registry 10th Annual Report 2007 Fig 9.6 Percentage of patients with serum phosphate ≥1.1-≤1.8mmol/L : HD

UK Renal Registry 10th Annual Report 2007 Fig 9.7 Percentage of patients with serum phosphate <1.8mmol/L : PD

UK Renal Registry 10th Annual Report 2007 Fig 9.7 Percentage of patients with serum phosphate ≥1.1-≤1.8mmol/L : PD

UK Renal Registry 10th Annual Report 2007 Fig 9.9 Percentage of patients with serum phosphate divided into bands

UK Renal Registry 10th Annual Report 2007 Fig 9.10 Funnel plot for percentage achievement of phosphate <1.8mmol/L:HD

UK Renal Registry 10th Annual Report 2007 Fig 9.11 Funnel plot for percentage achievement of phosphate ≥1.1-≤1.8mmol/L :HD

UK Renal Registry 10th Annual Report 2007 Fig 9.12 Funnel plot of percentage achievement of phosphate <1.8mmol/L:PD

UK Renal Registry 10th Annual Report 2007 Fig 9.13 Funnel plot of percentage achievement of phosphate ≥1.1-≤1.8mmol/L:PD

UK Renal Registry 10th Annual Report 2007 Fig 9.14 Annual change in percentage of dialysis patients achieving serum corrected Ca ≥2.2-≤2.6mmol/L split by modality

UK Renal Registry 10th Annual Report 2007 Fig 9.15 Percentage of patients with corrected calcium ≥2.2-≤2.6mmol/L : HD

UK Renal Registry 10th Annual Report 2007 Fig 9.16 Funnel plot of percentage achieving corrected calcium ≥2.2-≤2.6mmol/L:HD

UK Renal Registry 10th Annual Report 2007 Fig 9.17 Percentage of patients with corrected calcium ≥2.2-≤2.6mmol/L : PD

UK Renal Registry 10th Annual Report 2007 Fig 9.18 Median calcium*phosphate product: Dialysis

UK Renal Registry 10th Annual Report 2007 Fig 9.19 Percentage of patients with calcium*phosphate product <4.4mmol²/L² : Haemodialysis

UK Renal Registry 10th Annual Report 2007 Fig 9.20 Funnel plot of percentage achieving Calcium*Phosphate product <4.4mmol²/L²:HD

UK Renal Registry 10th Annual Report 2007 Fig 9.21 Percentage of patients with calcium*phosphate product <4.4mmol²/L²: Peritoneal dialysis

UK Renal Registry 10th Annual Report 2007 Fig 9.22 Percentage of patients with Calcium*phosphate product <4.8mmol²/L²: Dialysis

UK Renal Registry 10th Annual Report 2007 Fig 9.23 Change in percentage of patients achieving serum corrected calcium*phosphate product ≤4.4 mmol²/L²

UK Renal Registry 10th Annual Report 2007 Fig 9.24 Median iPTH in dialysis patients

UK Renal Registry 10th Annual Report 2007 Fig 9.25 Percentage of patients on dialysis with iPTH < 32 pmol/L

UK Renal Registry 10th Annual Report 2007 Fig 9.26 Percentage of patients on dialysis with iPTH pmol/L

UK Renal Registry 10th Annual Report 2007 Fig 9.27 Median serum bicarbonate : Haemodialysis

UK Renal Registry 10th Annual Report 2007 Fig 9.28 Percentage of patients with bicarbonate ≥20-≤26mmol/L : Haemodialysis

UK Renal Registry 10th Annual Report 2007 Fig 9.29 Percentage with serum bicarbonate ≥20-≤26mmol/L: HD

UK Renal Registry 10th Annual Report 2007 Fig 9.30 Median serum bicarbonate : Peritoneal dialysis

UK Renal Registry 10th Annual Report 2007 Fig 9.31 Percentage of patients with bicarbonate ≥25-≤29mmol/L : Peritoneal dialysis

UK Renal Registry 10th Annual Report 2007 Fig 9.32 Percentage with serum bicarbonate ≥25-≤29mmol/L:PD

UK Renal Registry 10th Annual Report 2007 Fig 9.33 Median serum total cholesterol: Dialysis

UK Renal Registry 10th Annual Report 2007 Fig 9.34 Median serum cholesterol: transplant

UK Renal Registry 10th Annual Report 2007 Fig 9.35 Serum cholesterol distribution by modality 31/12/2006

UK Renal Registry 10th Annual Report 2007 Fig 9.36 Percentage of patients with cholesterol ≤5mmol/L, , England, Wales and Northern Ireland

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.